Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cabanillas

Showing results (31-40 of 321) with videos related to

Pageof 33
Sort By:
Medicina Clinica|March 16, 1991
[The significance of the dosage strength in the response to cytotoxic drugs]J Rodríguez Díaz-Pavón, F Cabanillas
Seminars in Oncology|December 1, 1990
Recent trends in the management of lymphomas at M.D. Anderson Cancer CenterF Cabanillas, M A Rodríguez, F Swan
Cancer Treatment Reports|August 1, 1980
Ifosfamide, methotrexate, and vincristine (IMV) combination chemotherapy as secondary treatment for patients with malignant lymphomaF Cabanillas, V Rodriguez, G P Bodey
Medical and Pediatric Oncology|January 1, 1978
Improvement in complete response rate, duration of response and survival with adriamycin combination chemotherapy for non-Hodgkin lymphoma: a prognostic factor comparison of two regimensF Cabanillas, V Rodriguez, E J Freireich
Leukemia & Lymphoma|February 1, 1994
Lymphomatous presentation of CD4+/CD8+ HTLV-1-related adult T-cell leukemia/lymphoma in an Iranian womanJ F Seymour, A Younes, F Cabanillas
Hematological Oncology|March 1, 1991
Chromosomal abnormalities in adult non-endemic Burkitt's lymphoma and leukemia: 22 new reports and a review of 148 cases from the literatureS M Kornblau, A Goodacre, F Cabanillas
The Lancet. Oncology|March 21, 2002
Mantle-cell lymphomaI Barista, J E Romaguera, F Cabanillas
Oncology (Williston Park, N.Y.)|July 11, 2000
CD26 in T-cell lymphomas: a potential clinical role?S Verstovsek, F Cabanillas, N H Dang
Blood|January 1, 1993
Analysis of the expression of the hybrid gene bcl-2/IgH in follicular lymphomasP Soubeyran, F Cabanillas, M S Lee
European Journal of Cancer Care|February 14, 1998
Low-grade non-Hodgkin's lymphoma--development of a new effective combination regimen (fludarabine, mitoxantrone and dexamethasone; FND)M J Keating, P McLaughlin, F Cabanillas
Pageof 33

Showing results (31-40 of 321) with videos related to

Sort By:
Pageof 33
Medicina Clinica|March 16, 1991
[The significance of the dosage strength in the response to cytotoxic drugs]J Rodríguez Díaz-Pavón, F Cabanillas
Seminars in Oncology|December 1, 1990
Recent trends in the management of lymphomas at M.D. Anderson Cancer CenterF Cabanillas, M A Rodríguez, F Swan
Cancer Treatment Reports|August 1, 1980
Ifosfamide, methotrexate, and vincristine (IMV) combination chemotherapy as secondary treatment for patients with malignant lymphomaF Cabanillas, V Rodriguez, G P Bodey
Medical and Pediatric Oncology|January 1, 1978
Improvement in complete response rate, duration of response and survival with adriamycin combination chemotherapy for non-Hodgkin lymphoma: a prognostic factor comparison of two regimensF Cabanillas, V Rodriguez, E J Freireich
Leukemia & Lymphoma|February 1, 1994
Lymphomatous presentation of CD4+/CD8+ HTLV-1-related adult T-cell leukemia/lymphoma in an Iranian womanJ F Seymour, A Younes, F Cabanillas
Hematological Oncology|March 1, 1991
Chromosomal abnormalities in adult non-endemic Burkitt's lymphoma and leukemia: 22 new reports and a review of 148 cases from the literatureS M Kornblau, A Goodacre, F Cabanillas
The Lancet. Oncology|March 21, 2002
Mantle-cell lymphomaI Barista, J E Romaguera, F Cabanillas
Oncology (Williston Park, N.Y.)|July 11, 2000
CD26 in T-cell lymphomas: a potential clinical role?S Verstovsek, F Cabanillas, N H Dang
Blood|January 1, 1993
Analysis of the expression of the hybrid gene bcl-2/IgH in follicular lymphomasP Soubeyran, F Cabanillas, M S Lee
European Journal of Cancer Care|February 14, 1998
Low-grade non-Hodgkin's lymphoma--development of a new effective combination regimen (fludarabine, mitoxantrone and dexamethasone; FND)M J Keating, P McLaughlin, F Cabanillas
Pageof 33